For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...
The number of cases will increase, but the rates seem to be declining with every birth cohort that reaches advanced ages, ...
A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...
Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.
Research shows those who later developed dementia performed significantly worse at the “triangle test” than those who ...
New research suggests that blood tests used to diagnose Alzheimer's disease have racial disparities. Here's what's going on ...
For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...
A recent study determined the lifetime risk of developing dementia is double that of previous estimates. But there’s good ...
An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...
New research warns that blood tests for Alzheimer’s disease may be unreliable, particularly for Black patients. A recent ...
News got a visit from a special guest on Friday morning to talk about the 20th annual Dementia Conference happening next week ...
A new study has found that an experimental drug appears to reduce the risk of Alzheimer' s-related dementia in people ...